Stago's 2024 CSR report is online
The Stago Group is strengthening its commitment to Corporate Social Responsibility (CSR) and publishing its first 2024 report.
In the world
Stago Group Companies
COVID-19 infection and thrombotic disorders
Since December 2019, COVID-19 is spreading worldwide and affecting people every day.
Main symptoms are fever and cough, and most of patients recover spontaneously.
However, about 1 in 6 patients can develop breathing difficulties and in some of them the disease progresses to a more systemic disease and multiple organ dysfunction (1). Patient’s risk stratification is key to optimize COVID-19 patients flow at hospital. Stratification is currently based on characteristics of severe pneumonia and on laboratory findings.
The newest additions to Stago’s Max Generation are intelligently designed to meet the needs of today’s laboratories.
Setting the standard with exclusive mechanical technology built into all Stago systems for more than 30 years, Stago’s Viscosity-Based Detection System consistently delivers the right result, the first time.
Covid 19 impact on Stago’s range
As part of our commitment to healthcare, Stago has been closely monitoring the development of Covid 19 worldwide, implementing several actions in the past few weeks.
Health Economics Outcomes evaluation of Stago D-dimer
Improved patient outcomes and experience, shorter length of stay and cost effectiveness drive the recognition of value in today’s rapidly-evolving and competitive healthcare environment.
Stago Webinar available on-demand!
The Stago webinars have successfully gathered colleagues from all around the world. If you have missed the live events or are interested in reviewing it, the 30-minute recorded version is now available online 24/7.
5th volume in Stago’s “Practical Manual in Haemostasis” collection
The last two volumes were devoted to anticoagulants (parenteral, then oral), it made sense that the Clinical Development Department had to turn its attention to another side with the exploration of bleeding disorders.
Stago continues to ditch paper!
In April 2017, Stago officially launched its IFU (Instruction for Use) platform at www.stago.com so that customers worldwide could visit and download reagent instructions, analyser reference manuals and safety data sheets that they need for their day-to-day work.
4th booklet in Stago’s “Practical Manual” collection: Oral anticoagulants
After the 3rd volume devoted to parental anticoagulants, it stands to reason that the Clinical Development Department had to turn its attention to the other side of anticoagulant treatment – the oral anticoagulants - in this series launched in 2014 with the objective of publishing a Practical Manual each year.
2017 American Association for Clinical Chemistry (AACC)
Stago hosted a record-breaking exhibition and charitable event at the 2017 American Association
for Clinical Chemistry (AACC) Annual Meeting and Clinical Lab Expo in San Diego, CA from
August 1st through August 3rd. With more than 21,000 attendees and 730 exhibitors,
the 2017 AACC expo was the largest yet.